News
Stanford Medicine researchers have developed a blood test capable of detecting cancers, the ways cancer resists treatments ...
Idiopathic pulmonary fibrosis (IPF) occurs when scar tissue builds up in the lungs, causing the walls to stiffen and making ...
Four physicians spoke on the panel, which was held at the Basketball Hall of Fame in Springfield, to discuss advancements in ...
In recent years, cell therapies have developed alongside chemotherapy and immunotherapy to become a new pillar in the treatment of patients with blood and lymph gland cancer. In solid tumors, such as ...
Akeso, a Chinese biotech that made headlines for beating Merck’s Keytruda in a head-to-head trial, won approval in China this ...
Presentations at this year’s American Association for Cancer Research meeting could have a broad impact on the treatment ...
A Rochester man celebrated being five years cancer-free Thursday by walking around Mayo Clinic thanking the doctors that saved his life.
A new artificial intelligence (AI) tool could soon help general practitioners (GPs) detect lung cancer in patients up to four ...
A program cochair said the agenda was designed to get attendees "out of their comfort zone." The Amercian Association for ...
BriaCell confirms complete resolution of lung metastasis at 4 months in Phase 1/2a trial using Bria-OTS immunotherapy in ...
Key treatments for Alzheimer’s, rare cancers, and infectious diseases are under review, with new vaccines and therapies like ...
Researchers have identified a potential new way to treat idiopathic pulmonary fibrosis (IPF), a deadly and currently incurable lung disease that affects more than 3 million people worldwide.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results